SigRM offers breakthrough in single-cell epitranscriptomics analysis

Researchers have developed a new tool that will help scientists study how genes are expressed in our cells.

Moderna cuts spending, and Sarepta’s ‘curse’ on Califf

Good morning. If you’re following the European Society for Medical Oncology meeting that starts tomorrow, sign up for our ESMO in 30 Seconds newsletter. My

September 12, 2024

FDA explains why it denied about 60% of non-oncology breakthrough therapy requests from 2017 to 2019

The FDA is offering a look into why it denied about 60% of all breakthrough therapy designation requests it received from the biopharma industry —

November 14, 2023

UnitedHealth discontinues a controversial brand amid scrutiny of algorithmic care denials

UnitedHealth Group and Optum are getting rid of the name of their tech-driven care management company just months after the company faced congressional criticism over

October 23, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.